The hematology workforce in the United States: past, present, and strategies for the future

Authors:

Abstract
From 2017 to 2021, the American Society of Hematology (ASH) conducted the largest study to date of the hematology workforce in the United States. The study highlighted a deficit in the classical hematology (CH) workforce. Despite the very high CH clinical volumes encountered by practicing hematologists and medical oncologists, <5% of all hematology and medical oncology fellows reported having a career focus in CH. The reason underlying this deficit was a lack of mentorship in CH compared with malignant hematology and solid tumor oncology. In this viewpoint article, we discuss factors shaping the US hematology workforce and how decades of inadequate investment in mentorship, research, and subspecialty training have contributed to low interest in CH among trainees. We present an overview of ASH’s many initiatives to grow the hematology clinical and research workforce in the United States and globally for the future of the field.

This publication has 50 references indexed in Scilit: